ValuEngine cut shares of Omega Healthcare Investors (NYSE:OHI) from a buy rating to a hold rating in a research report report published on Wednesday.

A number of other analysts also recently commented on OHI. Zacks Investment Research upgraded Omega Healthcare Investors from a sell rating to a hold rating in a research report on Thursday, August 16th. began coverage on Omega Healthcare Investors in a research report on Tuesday, October 2nd. They set a neutral rating and a $31.00 target price on the stock. They noted that the move was a valuation call. Mitsubishi UFJ Financial Group reissued a neutral rating on shares of Omega Healthcare Investors in a report on Tuesday, October 2nd. Stifel Nicolaus set a $34.00 price target on Omega Healthcare Investors and gave the stock a hold rating in a report on Monday, November 5th. Finally, TheStreet raised Omega Healthcare Investors from a c rating to a b- rating in a report on Thursday, November 8th. Eight research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. The company has an average rating of Hold and an average target price of $32.50.

OHI opened at $36.70 on Wednesday. The company has a current ratio of 4.17, a quick ratio of 4.17 and a debt-to-equity ratio of 1.21. The firm has a market cap of $7.37 billion, a price-to-earnings ratio of 11.84, a PEG ratio of 7.11 and a beta of 0.17. Omega Healthcare Investors has a one year low of $24.90 and a one year high of $38.34.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Monday, November 5th. The real estate investment trust reported $0.28 EPS for the quarter, missing the Zacks’ consensus estimate of $0.74 by ($0.46). The firm had revenue of $192.30 million for the quarter, compared to analysts’ expectations of $194.40 million. Omega Healthcare Investors had a return on equity of 7.32% and a net margin of 31.91%. The firm’s revenue for the quarter was down .9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.79 earnings per share. On average, equities analysts anticipate that Omega Healthcare Investors will post 2.97 earnings per share for the current year.

In other news, insider Michael Ritz sold 6,000 shares of the business’s stock in a transaction on Friday, November 16th. The stock was sold at an average price of $34.75, for a total value of $208,500.00. Following the completion of the transaction, the insider now directly owns 10,076 shares of the company’s stock, valued at $350,141. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Steven J. Insoft sold 25,000 shares of the business’s stock in a transaction on Tuesday, December 11th. The stock was sold at an average price of $37.25, for a total value of $931,250.00. Following the completion of the transaction, the insider now directly owns 315,720 shares of the company’s stock, valued at $11,760,570. The disclosure for this sale can be found here. Over the last three months, insiders sold 36,000 shares of company stock valued at $1,321,750. Insiders own 1.65% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Belpointe Asset Management LLC acquired a new position in Omega Healthcare Investors in the third quarter valued at $131,000. Stratos Wealth Partners LTD. acquired a new position in Omega Healthcare Investors in the third quarter valued at $132,000. Meeder Asset Management Inc. increased its stake in Omega Healthcare Investors by 69.3% in the third quarter. Meeder Asset Management Inc. now owns 4,184 shares of the real estate investment trust’s stock valued at $137,000 after purchasing an additional 1,712 shares during the last quarter. Point72 Hong Kong Ltd acquired a new position in Omega Healthcare Investors in the second quarter valued at $147,000. Finally, Bell Rock Capital LLC acquired a new position in Omega Healthcare Investors in the third quarter valued at $158,000. 73.42% of the stock is owned by institutional investors.

Omega Healthcare Investors Company Profile

Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.

See Also: Should you buy a closed-end mutual fund?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.